The Peter MacCallum Cancer Centre’s Professor Grant McArthur will spearhead a new era of Victorian melanoma and skin cancer research following his appointment as the inaugural Lorenzo Galli Chair in Melanoma and Skin Cancers.
Health Professional Events
2014 Conferences
June 26 – 27, 4th European Post-Chicago Melanoma / Skin Cancer Meeting, Munich, Germany http://melanomaglobal2014.org/ July 6 – 11, European Society for Plastic, Reconstructive and Aesthetic Surgery Congress, Edinburgh, Scotland…
Read More Novel Immunotherapeutic Safe and Effective in Early-Phase Melanoma Study
A novel immunotherapeutic known as IMCgp100 induced clinical responses with manageable toxicity in patients with advanced melanoma, according to results from a phase I clinical trial presented at the 2014 AACR Annual Meeting.
T-VEC superior to GM-CSF for unresected, metastatic melanoma
Secondary endpoint results from a multicenter, randomized phase 3 trial showed talimogene laherparepvec conferred greater benefit than granulocyte-macrophage colony-stimulating factor for patients with unresected stage IIIB/IIIC or stage IV melanoma, according to study results presented at the HemOnc Today Melanoma and Cutaneous Malignancies meeting in New York.